251 related articles for article (PubMed ID: 22898085)
1. Prognostic factors and clinical outcomes in synovial sarcoma of the extremities.
Wisanuyotin T; Radapat K; Sirichativapee W; Paholpak P; Kosuwon W; Sumnanoont C; Jeeravipoolvarn P
Asia Pac J Clin Oncol; 2013 Mar; 9(1):80-5. PubMed ID: 22898085
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of clinical outcomes and prognostic factors for synovial sarcoma arising from the extremities.
Sakabe T; Murata H; Konishi E; Takeshita H; Ueda H; Matsui T; Horie N; Yanagisawa A; Kubo T
Med Sci Monit; 2008 Jun; 14(6):CR305-310. PubMed ID: 18509273
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant radiotherapy for pediatric and young adult nonrhabdomyosarcoma soft-tissue sarcoma.
Smith KB; Indelicato DJ; Knapik JA; Lagmay JP; Morris C; Kirwan JM; Zlotecki RA; Scarborough MT; Gibbs CP; Marcus RB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):150-7. PubMed ID: 21550181
[TBL] [Abstract][Full Text] [Related]
4. Synovial sarcoma involving skull base--a retrospective analysis of diagnosis and treatment of 21 cases in one institution.
Ji T; Ma CY; Ow A; Wang LZ; Sun J; Zhang CP
Oral Oncol; 2011 Jul; 47(7):671-6. PubMed ID: 21641853
[TBL] [Abstract][Full Text] [Related]
5. [Retrospective analysis and prognostic factors of 208 cases of primary soft tissue sarcoma of extremity].
Li Y; Niu XH; Xu HR
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):964-9. PubMed ID: 22333413
[TBL] [Abstract][Full Text] [Related]
6. The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.
ten Heuvel SE; Hoekstra HJ; Bastiaannet E; Suurmeijer AJ
Appl Immunohistochem Mol Morphol; 2009 May; 17(3):189-95. PubMed ID: 18997619
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of prognostic factors for synovial sarcoma].
Du ZY; Guo W; Yang RL; Yan TQ; Li DS
Zhonghua Wai Ke Za Zhi; 2011 Nov; 49(11):991-4. PubMed ID: 22333419
[TBL] [Abstract][Full Text] [Related]
8. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.
Guillou L; Benhattar J; Bonichon F; Gallagher G; Terrier P; Stauffer E; Somerhausen Nde S; Michels JJ; Jundt G; Vince DR; Taylor S; Genevay M; Collin F; Trassard M; Coindre JM
J Clin Oncol; 2004 Oct; 22(20):4040-50. PubMed ID: 15364967
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients.
Zagars GK; Ballo MT; Pisters PW; Pollock RE; Patel SR; Benjamin RS; Evans HL
Cancer; 2003 May; 97(10):2530-43. PubMed ID: 12733153
[TBL] [Abstract][Full Text] [Related]
10. Synovial sarcoma: the importance of size and location for survival.
Deshmukh R; Mankin HJ; Singer S
Clin Orthop Relat Res; 2004 Feb; (419):155-61. PubMed ID: 15021147
[TBL] [Abstract][Full Text] [Related]
11. The outcomes and prognostic factors of patients with soft-tissue sarcoma.
Kiatisevi P; Asavamongkolkul A; Phimolsarnti R; Waikakul S; Benjarassamerote S
J Med Assoc Thai; 2006 Mar; 89(3):334-42. PubMed ID: 16696417
[TBL] [Abstract][Full Text] [Related]
12. [Synovial sarcoma of the extremities. Results of surgical and multimodal therapy].
Ulmer C; Kettelhack C; Tunn PU; Reichardt P; Hohenberger P; Schlag PM
Chirurg; 2003 Apr; 74(4):370-4. PubMed ID: 12719879
[TBL] [Abstract][Full Text] [Related]
13. Synovial sarcoma: a review of 33 cases.
Buck P; Mickelson MR; Bonfiglio M
Clin Orthop Relat Res; 1981 May; (156):211-5. PubMed ID: 6164515
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.
Takenaka S; Ueda T; Naka N; Araki N; Hashimoto N; Myoui A; Ozaki T; Nakayama T; Toguchida J; Tanaka K; Iwamoto Y; Matsumine A; Uchida A; Ieguchi M; Kaya M; Wada T; Baba I; Kudawara I; Aoki Y; Yoshikawa H
Oncol Rep; 2008 Feb; 19(2):467-76. PubMed ID: 18202796
[TBL] [Abstract][Full Text] [Related]
15. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity.
Lewis JJ; Antonescu CR; Leung DH; Blumberg D; Healey JH; Woodruff JM; Brennan MF
J Clin Oncol; 2000 May; 18(10):2087-94. PubMed ID: 10811674
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma.
Hasegawa T; Yokoyama R; Matsuno Y; Shimoda T; Hirohashi S
Hum Pathol; 2001 Mar; 32(3):257-63. PubMed ID: 11274633
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological features of patients with resected synovial sarcoma: a multicenter retrospective analysis of the Anatolian Society of Medical Oncology.
Tarkan Y; Erkan A; Selcuk ES; Mehmet K; Tugba KF; Ozlem US; Suleyman A; Tulay A; Bilge A; Ramazan Y; Yusuf G; Mevlude I; Umut D; Ilhan O; Abdurrahman I; Alper S; Dogan U; Necati A; Berna O; Gok DA; Ugur Y; Mahmut G
J Cancer Res Ther; 2014; 10(1):73-8. PubMed ID: 24762490
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic analysis of 151 patients with maxillary sinus malignant neoplasms].
Guo GF; Yang AK; Xie RH; Chen ZH; Wu QL; Ou SM; Liu WW; Xia LP; Chen MY; Zhang JX; Wu JH
Ai Zheng; 2004 Nov; 23(11 Suppl):1546-50. PubMed ID: 15566677
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes for synovial sarcoma treated with conservation surgery and radiotherapy.
Guadagnolo BA; Zagars GK; Ballo MT; Patel SR; Lewis VO; Pisters PW; Benjamin RS; Pollock RE
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1173-80. PubMed ID: 17689031
[TBL] [Abstract][Full Text] [Related]
20. Synovial sarcoma relapses in children and adolescents: prognostic factors, treatment, and outcome.
Soole F; Maupain C; Defachelles AS; Taque S; Minard-Colin V; Bergeron C; De Rycke Y; Orbach D
Pediatr Blood Cancer; 2014 Aug; 61(8):1387-93. PubMed ID: 24664883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
